MnAGenome

A flagship product of Culturelytics, it provides data-driven cultural insights to sharpen merger & acquisition strategies. The challenge: accurate ‘cultural due diligence’ Globally, mergers and acquisitions worth a total of nearly $5 trillion take place every year. The number of deals is growing rapidly, while they become more complex involving multiple markets and industries. According to recent studies, more than 80% fail to create value – more than 70% due in part to cultural misalignment and more than 20% due primarily to culture. Yet ‘cultural due diligence’ is virtually unknown because investors lack a clear way to measure culture. Solution: MnA Genome For the first time, MnA GenomeTM combines the power of artificial intelligence (AI) with the latest thinking in organizational behavior to provide business leaders with the culture insights they need to make informed investment decisions. Prior to a merger or acquisition, it allows the buyer to perform data-driven cultural due diligence – defining how well the target company’s culture is aligned to the goals of the combined organization, as well as the financial impact of cultural alignment or misalignment. Investors are now able to: Go beyond anecdotes to gain accurate, reliable, actionable insights into organizational culture. Measure the financial impact of culture. Drive growth by aligning culture to the business mandate. Conduct informed ‘cultural due diligence’ for smarter investment decisions. Communicate better with investors about the impact of culture on ROI